Cargando…
One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN
BACKGROUND: Since the beginning of the COVID-19 pandemic, MetabERN has been monitoring the SARS-CoV-2 infection rates within its metabolic community. To gather data on the total number of cases and the severity of symptoms among IMD patients one year into the pandemic, an online survey was distribut...
Autores principales: | Paneghetti, Laura, Bellettato, Cinzia Maria, Sechi, Annalisa, Stepien, Karolina M., Scarpa, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894822/ https://www.ncbi.nlm.nih.gov/pubmed/35246188 http://dx.doi.org/10.1186/s13023-022-02247-3 |
Ejemplares similares
-
Social and medical needs of rare metabolic patients: results from a MetabERN survey
por: Sestini, Sylvia, et al.
Publicado: (2021) -
Research activity and capability in the European reference network MetabERN
por: Heard, Jean-Michel, et al.
Publicado: (2019) -
The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys
por: Lampe, C., et al.
Publicado: (2020) -
Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network
por: Heard, Jean-Michel, et al.
Publicado: (2020) -
Possible strategies to cross the blood–brain barrier
por: Bellettato, Cinzia M., et al.
Publicado: (2018)